Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 17  •  04:00PM ET
2.18
Dollar change
-0.02
Percentage change
-0.91
%
Apr 16, 8:55 AMBiomerica gains clarified Medicare reimbursement pathway as MAC confirms inFoods IBS test claims review under existing $300 CMS rate
Index
-
P/E
-
EPS (ttm)
-1.50
Insider Own
15.02%
Shs Outstand
3.03M
Perf Week
2.35%
Market Cap
6.74M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
2.63M
Perf Month
1.87%
Enterprise Value
5.59M
PEG
-
EPS next Q
-
Inst Own
2.89%
Perf Quarter
-18.66%
Income
-4.17M
P/S
1.56
EPS this Y
-
Inst Trans
-2.96%
Perf Half Y
-23.78%
Sales
4.33M
P/B
1.99
EPS next Y
-
ROA
-68.12%
Perf YTD
-13.49%
Book/sh
1.09
P/C
5.03
EPS next 5Y
-
ROE
-94.32%
52W High
4.60 -52.61%
Perf Year
-43.24%
Cash/sh
0.43
P/FCF
-
EPS past 3/5Y
8.87% -3.30%
ROIC
-125.84%
52W Low
1.87 16.80%
Perf 3Y
-84.25%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-34.47% -4.52%
Gross Margin
4.32%
Volatility
3.98% 4.38%
Perf 5Y
-94.25%
Dividend TTM
-
EV/Sales
1.29
EPS Y/Y TTM
32.96%
Oper. Margin
-123.74%
ATR (14)
0.11
Perf 10Y
-82.31%
Dividend Ex-Date
-
Quick Ratio
1.59
Sales Y/Y TTM
-23.81%
Profit Margin
-96.49%
RSI (14)
53.41
Dividend Gr. 3/5Y
- -
Current Ratio
2.64
EPS Q/Q
10.14%
SMA20
1.94%
Beta
0.28
Payout
-
Debt/Eq
0.06
Sales Q/Q
-11.80%
SMA50
2.34%
Rel Volume
0.46
Prev Close
2.20
Employees
54
LT Debt/Eq
0.00
Earnings
-
SMA200
-17.93%
Avg Volume
22.48K
Price
2.18
IPO
Mar 17, 1980
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
10,249
Change
-0.91%
Date Action Analyst Rating Change Price Target Change
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Apr-16-26 08:19AM
Apr-14-26 08:19AM
Apr-13-26 06:57PM
Mar-18-26 08:19AM
Mar-05-26 08:19AM
08:19AM Loading…
Feb-26-26 08:19AM
Feb-18-26 08:19AM
Jan-14-26 05:17PM
Dec-23-25 08:19AM
Dec-11-25 08:08AM
Nov-25-25 08:19AM
Nov-06-25 08:19AM
Oct-16-25 08:19AM
Oct-15-25 09:27AM
Oct-08-25 08:19AM
08:08AM Loading…
Sep-09-25 08:08AM
Sep-03-25 08:19AM
Aug-29-25 05:12PM
Aug-18-25 05:07AM
Aug-14-25 10:30AM
08:19AM
Jul-02-25 08:08AM
Jun-26-25 08:19AM
Jun-06-25 09:30AM
Jun-05-25 08:19AM
May-22-25 08:19AM
May-07-25 08:19AM
Apr-23-25 08:19AM
Apr-21-25 09:02AM
Apr-17-25 08:19AM
09:00AM Loading…
Apr-16-25 09:00AM
Apr-15-25 08:19AM
Feb-27-25 05:18AM
Feb-26-25 08:19AM
Feb-19-25 08:19AM
Jan-17-25 10:48AM
Jan-16-25 08:19AM
Jan-15-25 08:19AM
Nov-21-24 08:19AM
Nov-07-24 09:09AM
Oct-30-24 08:19AM
Oct-16-24 09:00AM
Sep-04-24 08:19AM
Aug-29-24 09:00AM
Jul-16-24 07:43AM
Jul-01-24 07:47AM
May-13-24 08:19AM
Apr-29-24 11:33AM
08:19AM
Apr-15-24 07:47AM
Apr-12-24 10:52PM
07:23PM
Mar-28-24 08:19AM
Feb-21-24 08:19AM
Jan-23-24 08:19AM
Jan-16-24 02:51PM
08:19AM
Dec-20-23 08:30AM
Dec-18-23 07:47AM
Nov-10-23 08:19AM
Nov-08-23 08:19AM
Oct-13-23 01:10PM
06:39AM
Sep-26-23 08:19AM
Sep-22-23 03:05PM
Aug-28-23 08:19AM
Aug-25-23 05:00PM
Aug-03-23 08:19AM
Jun-21-23 08:19AM
May-18-23 08:19AM
Apr-17-23 07:47AM
Apr-14-23 04:48PM
Mar-08-23 08:19AM
Mar-07-23 04:39PM
Mar-03-23 07:30AM
Mar-02-23 05:15PM
Feb-20-23 05:57AM
Jan-23-23 06:00AM
Jan-13-23 06:39PM
Jan-10-23 08:19AM
Dec-08-22 08:19AM
Dec-01-22 05:12AM
Nov-02-22 08:19AM
Oct-14-22 10:24AM
09:46AM
09:18AM
Oct-13-22 04:50PM
Oct-11-22 06:25AM
Sep-29-22 08:19AM
Aug-31-22 06:25AM
Aug-30-22 08:19AM
Aug-29-22 04:41PM
Jul-14-22 11:50AM
08:19AM
Jun-23-22 08:19AM
May-16-22 01:20PM
May-12-22 08:19AM
Apr-26-22 08:19AM
Apr-14-22 08:37AM
Feb-08-22 12:27PM
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.